-
1
-
-
0024376173
-
RAS Oncogenes in human cancer: A review
-
J.L. Bos Ras oncogenes in human cancer: a review Cancer Res. 49 1989 4682 4689 (Pubitemid 19213607)
-
(1989)
Cancer Research
, vol.49
, Issue.17
, pp. 4682-4689
-
-
Bos, J.L.1
-
2
-
-
0037805547
-
RAS oncogenes: The first 30 years
-
DOI 10.1038/nrc1097
-
M. Malumbres, and M. Barbacid RAS oncogenes: the first 30 years Nat. Rev. Cancer 3 2003 459 465 (Pubitemid 37328850)
-
(2003)
Nature Reviews Cancer
, vol.3
, Issue.6
, pp. 459-465
-
-
Malumbres, M.1
Barbacid, M.2
-
3
-
-
0037264633
-
Targeting RAS signalling pathways in cancer therapy
-
DOI 10.1038/nrc969
-
J. Downward Targeting RAS signalling pathways in cancer therapy Nat. Rev. Cancer 3 2003 11 22 (Pubitemid 37328883)
-
(2003)
Nature Reviews Cancer
, vol.3
, Issue.1
, pp. 11-22
-
-
Downward, J.1
-
4
-
-
33746434378
-
Cancer targets in the Ras pathway
-
DOI 10.1101/sqb.2005.70.044
-
P. Rodriguez-Viciana, O. Tetsu, K. Oda, J. Okada, K. Rauen, and F. McCormick Cancer targets in the Ras Pathway Cold Spring Harb. Symp. Quant. Biol. 70 2005 461 467 (Pubitemid 44124902)
-
(2005)
Cold Spring Harbor Symposia on Quantitative Biology
, vol.70
, pp. 461-467
-
-
Rodriguez-Viciana, P.1
Tetsu, O.2
Oda, K.3
Okada, J.4
Rauen, K.5
McCormick, F.6
-
5
-
-
0038311995
-
Ras family signaling: Therapeutic targeting
-
A.D. Cox, and C.J. Der Ras family signaling: therapeutic targeting Cancer Biol. Ther. 1 2002 599 606
-
(2002)
Cancer Biol. Ther.
, vol.1
, pp. 599-606
-
-
Cox, A.D.1
Der, C.J.2
-
6
-
-
77949430065
-
The Akt/PKB family of protein kinases: A review of small molecule inhibitors and progress towards target validation: A 2009 update
-
C.W. Lindsley The Akt/PKB family of protein kinases: a review of small molecule inhibitors and progress towards target validation: a 2009 update Curr. Top. Med. Chem. 10 2010 458 477
-
(2010)
Curr. Top. Med. Chem.
, vol.10
, pp. 458-477
-
-
Lindsley, C.W.1
-
7
-
-
2542547908
-
Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation
-
S.B. Kondapaka, S.S. Singh, G.P. Dasmahapatra, E.A. Sausville, and K.K. Roy Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation Mol. Cancer Ther. 2 2003 1093 1103
-
(2003)
Mol. Cancer Ther.
, vol.2
, pp. 1093-1103
-
-
Kondapaka, S.B.1
Singh, S.S.2
Dasmahapatra, G.P.3
Sausville, E.A.4
Roy, K.K.5
-
8
-
-
0037331989
-
Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase-Akt/PKB survival pathway
-
DOI 10.1097/00001813-200302000-00011
-
G.A. Ruiter, S.F. Zerp, H. Bartelink, W.J. van Blitterswijk, and M. Verheij Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase-Akt/PKB survival pathway Anticancer Drugs 14 2003 167 173 (Pubitemid 36269756)
-
(2003)
Anti-Cancer Drugs
, vol.14
, Issue.2
, pp. 167-173
-
-
Ruiter, G.A.1
Zerp, S.F.2
Bartelink, H.3
Van Blitterswijk, W.J.4
Verheij, M.5
-
9
-
-
0242708738
-
Small-molecule cyclin-dependent kinase modulators
-
A.M. Senderowicz Small-molecule cyclin-dependent kinase modulators Oncogene 22 2003 6609 6620 (Pubitemid 37372341)
-
(2003)
Oncogene
, vol.22
, Issue.43
, pp. 6609-6620
-
-
Senderowicz, A.M.1
-
10
-
-
0041324624
-
Novel direct and indirect cyclin-dependent kinase modulators for the prevention and treatment of human neoplasms
-
A.M. Senderowicz Novel direct and indirect cyclin-dependent kinase modulators for the prevention and treatment of human neoplasms Cancer Chemother. Pharmacol. 52 Suppl. 1 2003 S61 S73
-
(2003)
Cancer Chemother. Pharmacol.
, vol.52
, Issue.SUPPL. 1
-
-
Senderowicz, A.M.1
-
11
-
-
22144450226
-
Tumor and normal tissue pharmacokinetics of perifosine, an oral anti-cancer alkylphospholipid
-
DOI 10.1007/s10637-005-1436-0
-
S.R. Vink, J.H. Schellens, W.J. van Blitterswijk, and M. Verheij Tumor and normal tissue pharmacokinetics of perifosine, an oral anti-cancer alkylphospholipid Invest. New Drugs 23 2005 279 286 (Pubitemid 40980350)
-
(2005)
Investigational New Drugs
, vol.23
, Issue.4
, pp. 279-286
-
-
Vink, S.R.1
Schellens, J.H.M.2
Van Blitterswijk, W.J.3
Verheij, M.4
-
12
-
-
2942628062
-
Akt mediates Ras downregulation of RhoB, a suppressor of transformation, invasion, and metastasis
-
DOI 10.1128/MCB.24.12.5565-5576.2004
-
K. Jiang, J. Sun, J. Cheng, J.Y. Djeu, S. Wei, and S. Sebti Akt mediates Ras downregulation of RhoB, a suppressor of transformation, invasion, and metastasis Mol. Cell. Biol. 24 2004 5565 5576 (Pubitemid 38738186)
-
(2004)
Molecular and Cellular Biology
, vol.24
, Issue.12
, pp. 5565-5576
-
-
Jiang, K.1
Sun, J.2
Cheng, J.3
Djeu, J.Y.4
Wei, S.5
Sebti, S.6
-
13
-
-
6344231714
-
Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility
-
DOI 10.1016/j.yexcr.2004.08.012, PII S0014482704004793
-
A.P. Wheeler, and A.J. Ridley Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility Exp. Cell Res. 301 2004 43 49 (Pubitemid 39388895)
-
(2004)
Experimental Cell Research
, vol.301
, Issue.1
, pp. 43-49
-
-
Wheeler, A.P.1
Ridley, A.J.2
-
14
-
-
1642276816
-
Rho proteins and cancer
-
DOI 10.1023/B:BREA.0000018423.47497.c6
-
A.J. Ridley Rho proteins and cancer Breast Cancer Res. Treat. 84 2004 13 19 (Pubitemid 38388856)
-
(2004)
Breast Cancer Research and Treatment
, vol.84
, Issue.1
, pp. 13-19
-
-
Ridley, A.J.1
-
15
-
-
1642268839
-
RhoC induces differential expression of genes involved in invasion and metastasis in MCF10A breast cells
-
DOI 10.1023/B:BREA.0000018426.76893.21
-
M. Wu, Z.F. Wu, C. Kumar-Sinha, A. Chinnaiyan, and S.D. Merajver RhoC induces differential expression of genes involved in invasion and metastasis in MCF10A breast cells Breast Cancer Res. Treat. 84 2004 3 12 (Pubitemid 38388855)
-
(2004)
Breast Cancer Research and Treatment
, vol.84
, Issue.1
, pp. 3-12
-
-
Wu, M.1
Wu, Z.-F.2
Kumar-Sinha, C.3
Chinnaiyan, A.4
Merajver, S.D.5
-
16
-
-
84861532378
-
NSC126188, a piperazine alkyl derivative, induces apoptosis via upregulation of RhoB in HeLa cells
-
B.K. Kim, D.M. Kim, K.S. Chung, S.K. Park, S.J. Choi, A. Song, K. Lee, C.W. Lee, K.B. Song, G. Han, J. Simon, H.M. Kim, and M. Won NSC126188, a piperazine alkyl derivative, induces apoptosis via upregulation of RhoB in HeLa cells Invest. New Drugs 2010
-
(2010)
Invest. New Drugs
-
-
Kim, B.K.1
Kim, D.M.2
Chung, K.S.3
Park, S.K.4
Choi, S.J.5
Song, A.6
Lee, K.7
Lee, C.W.8
Song, K.B.9
Han, G.10
Simon, J.11
Kim, H.M.12
Won, M.13
-
17
-
-
0037311226
-
Rapid induction of apoptosis by combination of flavopiridol and tumor necrosis factor (TNF)-α or TNF-related apoptosis-inducing ligand in human cancer cell lines
-
D.M. Kim, S.Y. Koo, K. Jeon, M.H. Kim, J. Lee, C.Y. Hong, and S. Jeong Rapid induction of apoptosis by combination of flavopiridol and tumor necrosis factor (TNF)-alpha or TNF-related apoptosis-inducing ligand in human cancer cell lines Cancer Res. 63 2003 621 626 (Pubitemid 36158139)
-
(2003)
Cancer Research
, vol.63
, Issue.3
, pp. 621-626
-
-
Kim, D.-M.1
Koo, S.-Y.2
Jeon, K.3
Kim, M.H.4
Lee, J.5
Hong, C.Y.6
Jeong, S.W.7
-
18
-
-
67349244880
-
A novel benzimidazole analogue inhibits the hypoxia-inducible factor (HIF)-1 p.thway
-
M.S. Won, N. Im, S. Park, S.K. Boovanahalli, Y. Jin, X. Jin, K.S. Chung, M. Kang, K. Lee, S.K. Park, H.M. Kim, B.M. Kwon, and J.J. Lee A novel benzimidazole analogue inhibits the hypoxia-inducible factor (HIF)-1 p.thway Biochem. Biophys. Res. Commun. 385 2009 16 21
-
(2009)
Biochem. Biophys. Res. Commun.
, vol.385
, pp. 16-21
-
-
Won, M.S.1
Im, N.2
Park, S.3
Boovanahalli, S.K.4
Jin, Y.5
Jin, X.6
Chung, K.S.7
Kang, M.8
Lee, K.9
Park, S.K.10
Kim, H.M.11
Kwon, B.M.12
Lee, J.J.13
|